A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophagus
Phase 2
- Conditions
- cervical esophageal cancer
- Registration Number
- JPRN-UMIN000001439
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1.have lymph node metastases at neck level II area 2.have active concomitant malignancy 3.A Hbs antigen is positive 4.pregnant or may be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Treatment compliance CR rate Progression free survival 3-year larynx preservation survival toxicity